CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera Pharmaceuticals, Inc. (Nasdaq: IDRA), today announced that it will provide an overview of its drug discovery and development programs targeted to Toll-like Receptors and a general corporate update at the 13th Annual BIO CEO & Investor Conference on Monday, February 14, 2011 at 4:00 p.m. ET at the Waldorf=Astoria in New York City.
